Rubius Therapeutics
RUBY
$0.02198
Share price
7.74%
Change (1 day)
-98.28%
Change (1 year)
Categories
EPS for Rubius Therapeutics (RUBY)
EPS in 2022 (TTM): -$2.38
According to Rubius Therapeutics 's latest financial reports the company's current EPS (TTM) is -$2.38. In 2021 the company made an earnings per share (EPS) of -$2.23 a decrease over its 2020 EPS that were of -$2.08.
EPS history for Rubius Therapeutics from 2018 to 2022
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2022 (TTM) | -$2.38 | 6.73% |
| 2021 | -$2.23 | 7.21% |
| 2020 | -$2.08 | 0.48% |
| 2019 | -$2.07 | -27.9% |
| 2018 | -$2.87 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$2.18 | -8.40% | 🇺🇸 USA |